There was a youtube video of Goran Ando addressing Baker Young stockbrokers in Adelaide pre Cbio cr for arthritis trial (subcutaneous) in which he stated that this drug (cpn10) will make it to market.
Also interesting to note in today's Courier Mail under heading of "Breath of good news on asthma" that the QIMR Berghoffer Medical Research Institute is to begin trailing arthritis drug "Tocilizumab" for asthma which suppresses the immune systems response to the protein IL-6 . Pre Clinical trials carried out on mice last year showed the drug worked to prevent or reduce asthma.It was discovered by this institute four years ago that the IL-6 receptor gene was faulty in asthmatics."(same effect cpn 10 had on mouse trials for Lupus IL-6)
IVX Price at posting:
5.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)